Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Ifi27em1/Cya
Common Name:
Ifi27-KO
Product ID:
S-KO-10347
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Ifi27-KO
Strain ID
KOCMP-52668-Ifi27-B6J-VA
Gene Name
Ifi27
Product ID
S-KO-10347
Gene Alias
1110013J02Rik; 2900026P10Rik; D12Ertd647e; ISG12a; Ifi27l1
Background
C57BL/6JCya
NCBI ID
52668
Modification
Conventional knockout
Chromosome
12
Phenotype
MGI:1277180
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Ifi27em1/Cya mice (Catalog S-KO-10347) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000085065
NCBI RefSeq
NM_026790
Target Region
Exon 3~7
Size of Effective Region
~4.8 kb
Detailed Document
Click here to download >>
Overview of Gene Research
IFI27, also known as IFN-α-inducible protein 27, is an interferon-stimulated gene (ISG) that plays diverse roles in the immune response, metabolism, and disease [2,3,4,6,8]. It is involved in pathways such as the innate immune response, regulation of the viral life cycle, and JAK-STAT signaling pathway [2]. IFI27 has been associated with various diseases including viral infections, cancer, and inflammatory disorders, highlighting its potential as a biomarker and therapeutic target [2,3,4,5,8,9].

In adipocytes, Ifi27-knockout leads to reduced expression of key enzymes in the tricarboxylic acid cycle, subunits of the electron transport chain, and uncoupling protein 1 (Ucp1), resulting in impaired oxygen consumption and defective thermogenesis [1,7]. This indicates that Ifi27 is crucial for mitochondrial function and adipocyte thermogenic adaptation [1,7]. In the context of viral infections, overexpression of IFI27 positively regulates DENV-2 infection, while knockdown has the opposite effect [2]. In HIV-1 infection, IFI27 is upregulated and can suppress HIV-1 replication by degrading the viral gag protein through the ubiquitin-proteasome pathway [4].

In conclusion, IFI27 is a multifunctional gene. Through gene knockout studies in adipocytes, its importance in mitochondrial function and thermogenesis has been revealed. In viral infections, its role in modulating the infection process has been demonstrated, suggesting that it could be a potential therapeutic target for treating viral diseases like HIV and dengue [1,2,4,7].

References:

1. Cui, Xuan, Liu, Haojie, Shi, Ting, Tang, Qi-Qun, Pan, Dongning. 2023. IFI27 Integrates Succinate and Fatty Acid Oxidation to Promote Adipocyte Thermogenic Adaption. In Advanced science (Weinheim, Baden-Wurttemberg, Germany), 10, e2301855. doi:10.1002/advs.202301855. https://pubmed.ncbi.nlm.nih.gov/37544897/

2. Jiang, Cheng, He, Cong, Kan, Jing, Zhou, Tao, Yang, Yi. . Integrative bulk and single-cell transcriptome profiling analysis reveals IFI27 as a novel interferon-stimulated gene in dengue. In Journal of medical virology, 95, e28706. doi:10.1002/jmv.28706. https://pubmed.ncbi.nlm.nih.gov/36971141/

3. Huang, Huijuan, Lv, Jiannan, Huang, Yonglun, Li, Hongmian, Qin, Yaqin. . IFI27 is a potential therapeutic target for HIV infection. In Annals of medicine, 54, 314-325. doi:10.1080/07853890.2021.1995624. https://pubmed.ncbi.nlm.nih.gov/35068272/

4. He, Wen-Qiang, Pang, Wei, Li, Na, Yang, Liu-Meng, Zheng, Yong-Tang. 2024. IFI27 inhibits HIV-1 replication by degrading Gag protein through the ubiquitin-proteasome pathway. In Journal of virology, 98, e0135624. doi:10.1128/jvi.01356-24. https://pubmed.ncbi.nlm.nih.gov/39475279/

5. Shojaei, Maryam, Shamshirian, Amir, Monkman, James, Short, Kirsty R, Tang, Benjamin. 2023. IFI27 transcription is an early predictor for COVID-19 outcomes, a multi-cohort observational study. In Frontiers in immunology, 13, 1060438. doi:10.3389/fimmu.2022.1060438. https://pubmed.ncbi.nlm.nih.gov/36685600/

6. Villamayor, Laura, López-García, Darío, Rivero, Vanessa, Nogales, Aitor, DeDiego, Marta L. 2023. The IFN-stimulated gene IFI27 counteracts innate immune responses after viral infections by interfering with RIG-I signaling. In Frontiers in microbiology, 14, 1176177. doi:10.3389/fmicb.2023.1176177. https://pubmed.ncbi.nlm.nih.gov/37187533/

7. Jin, Weiwei, Jin, Wenfang, Pan, Dongning. 2018. Ifi27 is indispensable for mitochondrial function and browning in adipocytes. In Biochemical and biophysical research communications, 501, 273-279. doi:10.1016/j.bbrc.2018.04.234. https://pubmed.ncbi.nlm.nih.gov/29730295/

8. Shojaei, Maryam, McLean, Anthony S. 2025. Interferon-stimulated gene IFI27 as a multifaceted candidate target in precision medicine. In Trends in immunology, 46, 219-228. doi:10.1016/j.it.2025.01.008. https://pubmed.ncbi.nlm.nih.gov/40044530/

9. Zhang, Ying, Chen, Chuangzhen, Liu, Zhaoyong, Hu, Wang, Lin, Zhixiong. 2022. PABPC1-induced stabilization of IFI27 mRNA promotes angiogenesis and malignant progression in esophageal squamous cell carcinoma through exosomal miRNA-21-5p. In Journal of experimental & clinical cancer research : CR, 41, 111. doi:10.1186/s13046-022-02339-9. https://pubmed.ncbi.nlm.nih.gov/35346324/

Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest